Search research articles
Contact Us
Filters
Showing results (141-150 of 159) with videos related to
Page
of 16
Sort By:
Breast Cancer Research and Treatment
|
December 27, 2011
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Laura J Esserman, Donald A Berry, Maggie C U Cheang, et al.
Cancer Cell
|
May 27, 2022
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
Denise M Wolf, Christina Yau, Julia Wulfkuhle, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2024
Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial
Robert W Mutter, Michael A Golafshar, Matthew R Buras, et al.
Nature Communications
|
February 26, 2026
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma
Paul B Romesser, Aron Bercz, Janet Alvarez, et al.
Annals of Surgery
|
August 7, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer
Stacey A Cohen, Vasily N Aushev, George Laliotis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer
Angela DeMichele, Douglas Yee, Donald A Berry, et al.
JAMA Oncology
|
February 14, 2020
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
Rita Nanda, Minetta C Liu, Christina Yau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis
Wolfgang Janni, Thomas W P Friedl, Tracy C Yab, et al.
Cancer Cell
|
November 18, 2022
Evaluation of cell-free DNA approaches for multi-cancer early detection
Arash Jamshidi, Minetta C Liu, Eric A Klein, et al.
The New England Journal of Medicine
|
July 14, 2016
Adaptive Randomization of Neratinib in Early Breast Cancer
John W Park, Minetta C Liu, Douglas Yee, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 159) with videos related to
Sort By:
Page
of 16
Breast Cancer Research and Treatment
|
December 27, 2011
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Laura J Esserman, Donald A Berry, Maggie C U Cheang, et al.
Cancer Cell
|
May 27, 2022
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
Denise M Wolf, Christina Yau, Julia Wulfkuhle, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2024
Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial
Robert W Mutter, Michael A Golafshar, Matthew R Buras, et al.
Nature Communications
|
February 26, 2026
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma
Paul B Romesser, Aron Bercz, Janet Alvarez, et al.
Annals of Surgery
|
August 7, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer
Stacey A Cohen, Vasily N Aushev, George Laliotis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer
Angela DeMichele, Douglas Yee, Donald A Berry, et al.
JAMA Oncology
|
February 14, 2020
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
Rita Nanda, Minetta C Liu, Christina Yau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis
Wolfgang Janni, Thomas W P Friedl, Tracy C Yab, et al.
Cancer Cell
|
November 18, 2022
Evaluation of cell-free DNA approaches for multi-cancer early detection
Arash Jamshidi, Minetta C Liu, Eric A Klein, et al.
The New England Journal of Medicine
|
July 14, 2016
Adaptive Randomization of Neratinib in Early Breast Cancer
John W Park, Minetta C Liu, Douglas Yee, et al.
Page
of 16